2023年和2024年澳大利亚成人流感与COVID-19疫苗接种的提供机构设置
研究基于澳大利亚免疫登记册中2023至2024年成人流感与COVID-19疫苗接种数据,关联澳大利亚人口普查社会人口信息,分析药房接种比例变化。结果显示2024年药房接种流感疫苗小幅增加(调整比值比1.16,95%CI 1.16-1.17),但药房接种在≥65岁、CALD背景及社会经济地位较低人群中比例较低。
要点
- 2023年流感疫苗61%在全科诊所接种、24%在药房接种;COVID-19疫苗54%在全科诊所、44%在药房接种。
- 两年中药房接种在≥65岁、CALD背景及收入/就业/教育较低成人中比例较低。
核心结论
- 扩大药房疫苗接种提供可能提高接种率,但需了解其对接种不足人群的影响。
研究设计与样本
- 基于澳大利亚免疫登记册2023至2024年报告的成人流感与COVID-19疫苗接种数据,关联澳大利亚人口普查社会人口信息进行分析。
主要发现
- 两年中药房接种疫苗在≥65岁( vs <65岁)、CALD背景( vs 非CALD)、收入/就业/教育较低( vs 较高)成人中比例较低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Australia expanded access to funded pharmacy vaccination in 2024. We examined changes in the proportion of adult pharmacy-administered vaccination. METHODS: Adult influenza and COVID-19 vaccinations reported in the Australian Immunisation Register from 2023 to 2024 linked to Australian Census socio-demographic information were assessed. RESULTS: In 2023, 61% of 7.49 million influenza and 54% of 4.61 million COVID-19 vaccinations were provided in general practices, compared to 24% and 44%, respectively, in pharmacies. While total vaccinations declined in 2024 (influenza: 7.04 million; COVID-19: 2.48 million) there was a small increase in pharmacy-administered influenza vaccinations (adjusted odds ratio 1.16 95%CI 1.16-1.17). In both years, a lower proportion of pharmacy-administered vaccinations were given to adults: aged ≥65 years (vs. <65 years); from culturally and linguistically diverse(CALD) backgrounds (vs. non-CALD); with lower incomes, employment and education (vs. higher). CONCLUSION: Expanding pharmacy provision of vaccinations may improve uptake, but understanding the impact on under-vaccinated populations is needed.
引用
- Reekie J, Stepien S, Hendry A, et al. Provider setting for influenza and COVID-19 vaccination among Australian adults in 2023 and 2024. Vaccine. 2025. PMID: 41202610. doi:10.1016/j.vaccine.2025.127945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。